Lovelace Biomedical Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Lovelace Biomedical's estimated annual revenue is currently $20.7M per year.(i)
  • Lovelace Biomedical's estimated revenue per employee is $201,000

Employee Data

  • Lovelace Biomedical has 103 Employees.(i)
  • Lovelace Biomedical grew their employee count by 0% last year.

Lovelace Biomedical's People

NameTitleEmail/Phone
1
VP Human Resources & SecurityReveal Email/Phone
2
Director Medical Outcomes ResearchReveal Email/Phone
3
Research Scientist/Study DirectorReveal Email/Phone
4
EVP, Chief Operating OfficerReveal Email/Phone
5
Director Translational Science (Drug Development/Medicine)Reveal Email/Phone
6
Sr. Director Translational Research-PharmacologyReveal Email/Phone
7
Associate HR DirectorReveal Email/Phone
8
Associate Director, Office Research Contracts and Project ManagementReveal Email/Phone
9
Former Associate Director FacilitiesReveal Email/Phone
10
Business Development Manager, West CoastReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.4M40%N/AN/A
#2
$22.9M114-2%N/AN/A
#3
$20.7M1030%N/AN/A
#4
$0.8M40%N/AN/A
Add Company

What Is Lovelace Biomedical?

Building on a history of pioneering science and technological innovation, Lovelace Biomedical is a contract research organization that helps pharmaceutical and biotechnology companies advance their discoveriesno matter how complexinto clinical testing and beyond. The organization leverages a multidisciplinary toolset to push the limits of preclinical research and fully understand the behavior of its clients investigational products. Lovelace Biomedical provides a unique experimental breadth and logistical capacity to solve specialized challenges that other CROs are not equipped to handle, featuring expansive bio-secure facilities and ongoing access to industry-leading scientific experts. The team thrives on developing programs for complex diseases, emerging drug classes and delivery mechanisms, and challenging areas of drug development while delivering the same level of rigor and attention to seemingly straightforward studies that are just as critical to regulatory success.

keywords:N/A

N/A

Total Funding

103

Number of Employees

$20.7M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Lovelace Biomedical News

2019-09-07 - Windtree Therapeutics Announces Publication of Results of Lung Deposition Study of Aerosolized Lucinactant

The study was performed in collaboration with Lovelace Biomedical and is published in the Journal of Aerosol Medicine and Pulmonary Drug ...

2019-07-11 - Lovelace Biomedical & Exemplar Genetics Win New Contract ...

ALBUQUERQUE, N.M., July 11, 2019 /PRNewswire/ -- Lovelace Biomedical and Exemplar Genetics have teamed together to win a contract ...

2019-01-22 - Lovelace Biomedical Wins 5 Year Gene Therapy Contract

ALBUQUERQUE, NM., Jan. 22, 2019 /PRNewswire/ -- Lovelace Biomedical has won a third consecutive 5-year support contract to provide ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$31.7M103-39%N/A
#2
$7.5M1059%N/A
#3
$23.1M10525%N/A
#4
$28.6M1062%N/A
#5
$19.4M1082%N/A